Nonetheless, prophylactic surgery remains recommended in children harboring RET mutations (MEN syndromes) and at risk of medullary thyroid carcinoma (MTC) onset, with the timing of surgery determined by the known progression risk of every specific mutated codon [2]. This evidence concerns the gene RET and multiple endocrine neoplasia.